查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1428046

2024 年組織微陣列全球市場報告

Tissue Microarray Global Market Report 2024
出版日期: 按訂單生產 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

組織微陣列市場規模預計在未來幾年將快速成長。預計到 2028 年將以 10.9% 的複合年成長率 (CAGR) 成長至 186.8 億美元。預測期內的預期成長是由數位病理學的出現、組織微陣列的適用性不斷擴大、生物製藥行業的成長、監管支持和標準以及人工智慧 (AI) 和機器學習的整合等因素推動的。認為是由於這個原因。預測期內的顯著趨勢包括成像技術的進步、3D 組織微陣列的開發、高內涵篩檢的採用、標準化工作以及單細胞分析方法的整合。

由於癌症病例數的增加，組織微陣列市場有望成長。以異常細胞增生和侵襲為特徵的癌症需要先進的診斷工具。組織晶片透過檢查各種腫瘤樣本中與癌症相關的生物標記物，在腫瘤學中發揮重要作用。根據美國癌症協會估計，2022年美國將有609,820例癌症死亡和1,958,310例新發癌症病例，導致癌症研究和診斷中對組織微陣列的需求凸顯。

對個人化醫療的需求不斷成長進一步推動了組織微陣列市場的成長。個人化醫療更有效地協調醫療保健。組織微陣列可用於同時分析多個組織樣本，促進生物標記的快速評估。 2022年，食品藥物管理局藥物評估與研究中心（CDER）核准了37個新分子實體（NME），其中約34%被歸類為個人化醫療。這凸顯了組織微陣列在促進個人化醫療方面的重要角色。

目錄

第1章執行摘要

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 全球組織微陣列市場的驅動與阻礙因素
    • 市場驅動力
    • 市場限制
  • 2018-2023 年全球組織微陣列市場規模、表現與成長
  • 2023-2028、2033年全球組織微陣列市場規模及成長預測

第6章市場區隔

  • 全球組織微陣列市場，按類型、實際和預測細分，2018-2023、2023-2028、2033
  • 免疫組織化學
  • 螢光原位雜合反應
  • 冷凍組織陣列
  • 其他類型
  • 全球組織微陣列市場，依技術、效能和預測細分，2018-2023、2023-2028、2033
  • 去氧核糖核酸(DNA) 微陣列
  • 聚合酵素鏈鎖反應(PCR)
  • 下一代定序
  • 北方印跡
  • 西方印漬術
  • 全球組織微陣列市場，按應用、實際和預測細分，2018-2023、2023-2028、2033
  • 腫瘤學
  • 基因表現
  • 單核苷酸多態性（SNP）檢測
  • 雙鏈B-DNA 微陣列
  • 比較雜合反應
  • 序列生物資訊學
  • 全球組織微陣列市場，按最終用戶細分、績效和預測，2018-2023、2023-2028、2033
  • 製藥和生物技術公司
  • 調查機構
  • 醫院

第 7 章 區域與國家分析

  • 全球組織微陣列市場，按地區、績效及預測，2018-2023、2023-2028、2033
  • 全球組織微陣列市場，依國家、表現及預測，2018-2023、2023-2028、2033

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭形勢及公司概況

  • 組織微陣列市場競爭形勢
  • 組織微陣列市場公司概況
    • Roche Group
    • Merck &Co. Inc.
    • Thermo Fisher Scientific Inc.
    • Becton, Dickinson Biosciences
    • Agilent Technologies Inc.

第31章 其他大型創新公司

  • Illumina Inc.
  • Bio-Rad Laboratories Inc.
  • Qiagen NV
  • PerkinElmer Inc.
  • Bio-Techne Corporation
  • Tristar Group
  • Evotec SE
  • Precision For Medicine Inc.
  • Molecular Devices LLC
  • BioIVT LLC
  • BioChain Institute Inc.
  • Creative Bioarray Co
  • 3DHISTECH Ltd.
  • Novus Biologicals LLC
  • OriGene Technologies Inc.

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章 重大併購

第35章 未來前景與可能性分析

第36章附錄

簡介目錄
Product Code: r13890

A tissue microarray is a high-throughput technology that enables comprehensive analysis of antigen expression across numerous tissues and cells in a single experiment, typically using paraffin blocks or formalin. It allows for the simultaneous assessment of protein expression in multiple tissue samples.

The primary types of tissue microarrays include immunohistochemistry, fluorescent in situ hybridization, frozen tissue array, and other variants. Immunohistochemistry (IHC) is a technique used to diagnose certain types of cancer, such as mesothelioma, by employing a visual marker to locate antigens in biopsy tissue. Various technologies such as DNA microarrays, polymerase chain reaction (PCR), next-generation sequencing, northern blotting, western blotting, and others are utilized for applications in oncology, gene expression profiling, single nucleotide polymorphism (SNP) detection, double-stranded B-DNA microarrays, comparative genomic hybridization, sequencing bioinformatics, and more. These technologies find applications across different end-users, including pharmaceutical and biotechnological companies, research organizations, and hospitals.

The tissue microarray research report is one of a series of new reports from The Business Research Company that provides tissue microarray market statistics, including the tissue microarray industry's global market size, regional shares, competitors with tissue microarray market share, detailed tissue microarray market segments, market trends and opportunities, and any further data you may need to thrive in the tissue microarray industry. This tissue microarray market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The tissue microarray market size has grown rapidly in recent years. It will grow from $11.17 billion in 2023 to $12.36 billion in 2024 at a compound annual growth rate (CAGR) of 10.7%. The growth observed in the historical period can be attributed to factors such as the rise of precision medicine, advancements in drug discovery and development, the efficient analysis enabled by tissue microarrays, the increasing prevalence of chronic diseases, and initiatives in biobanking.

The tissue microarray market size is expected to see rapid growth in the next few years. It will grow to $18.68 billion in 2028 at a compound annual growth rate (CAGR) of 10.9%. The anticipated growth in the forecast period can be attributed to factors such as the emergence of digital pathology, expanded applications of tissue microarrays, the growth of the biopharmaceutical industry, regulatory support and standards, and the integration of artificial intelligence (AI) and machine learning. Noteworthy trends in the forecast period include advancements in imaging technologies, the development of 3D tissue microarrays, the adoption of high-content screening, standardization initiatives, and the integration of single-cell analysis methods.

The tissue microarray market is poised for growth, driven by the increasing number of cancer cases. Cancer, characterized by abnormal cell proliferation and invasion, necessitates advanced diagnostic tools. Tissue arrays play a crucial role in oncology by examining cancer-related biomarkers in various tumor samples. According to the American Cancer Society Inc., it is estimated that there will be 609,820 cancer deaths and 1,958,310 new cancer cases in the US during 2022, underscoring the demand for tissue microarrays in cancer research and diagnosis.

The growth of the tissue microarray market is further fueled by the rising demand for personalized medicine. Personalized medicine tailors medical treatment to individual characteristics for more effective healthcare. Tissue microarrays are instrumental in analyzing multiple tissue samples concurrently, facilitating rapid assessment of biomarkers. In 2022, the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs), with approximately 34% classified as personalized medicines. This emphasizes the integral role of tissue microarrays in advancing personalized medicine.

A notable trend in the tissue microarray market is the emergence of strategic partnerships. Major companies in the market are forming alliances to develop innovative tissue microarray technologies. For instance, The Cureline Group partnered with Cellecta Inc. to launch Tissue 2 Target Services, combining their competencies in molecular analysis and biospecimen management. Another collaboration involves Ultivue Inc. and ngTMA, aiming to advance multiplexed immunofluorescence assays and apply new tissue microarray technologies for spatial analysis in scientific research.

Companies in the tissue microarray market are focusing on advanced solutions, such as microarray platforms, to enhance precision and efficiency in high-throughput tissue analysis. MARGenomics launched the Applied Biosystems GeneChip 3000 Dx v2, an advanced microarray platform, the first in Europe and the United States to receive regulatory approval for diagnostic purposes. This platform, funded by the Carlos III Health Institute and the European Union's NextGenerationEU initiative, offers diverse functionalities for genomic and expression microarrays.

In July 2021, BioIVT acquired Tissue Solutions Ltd., expanding access to high-quality disease state and control biospecimens. Tissue Solutions Ltd., a virtual biobank based in the UK, provides human tissue and biological materials to researchers for various applications, including drug discovery, target identification, assay creation, and biomarker development. This acquisition enhances BioIVT's capabilities and geographic reach with an addition of 150 collection sites.

Major companies operating in the tissue microarray market report are Roche Group, Merck & Co. Inc., Thermo Fisher Scientific Inc., Becton, Dickinson Biosciences, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Qiagen NV, PerkinElmer Inc., Bio-Techne Corporation, Tristar Group, Evotec SE, Precision For Medicine Inc., Molecular Devices LLC, BioIVT LLC, BioChain Institute Inc., Creative Bioarray Co, 3DHISTECH Ltd., Novus Biologicals LLC, OriGene Technologies Inc., PREMIER Biosoft International Inc., iSpecimen Inc., OriGene Technologies Inc., Bio SB Inc., ProteoGenex Inc., Z Biotech LLC

North America was the largest region in the tissue microarray market in 2023. Asia-Pacific is expected to be the fastest-growing region in the tissue microarray market report during the forecast period. The regions covered in the tissue microarray market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the tissue microarray market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The tissue microarray market consists of sales of molds, needles, and tissue punches. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tissue Microarray Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tissue microarray market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tissue microarray ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The tissue microarray market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Type: Immunohistochemistry; Fluorescent In Situ Hybridization; Frozen Tissue Array; Other Types
  • 2) By Technology: Deoxyribonucleic Acid (DNA) Microarray; Polymerase Chain Reaction (PCR); Next-Generation Sequencing; Northern Blotting; Western Blotting
  • 3) By Application: Oncology; Gene Expression Profiling; Single Nucleotide Polymorphism (SNP) Detection; Double-Stranded B-DNA Microarrays; Comparative Genomic Hybridization; Sequencing Bioinformatics
  • 4) By End-User: Pharmaceutical And Biotechnological Companies; Research Organization; Hospitals
  • Companies Mentioned: Roche Group; Merck & Co. Inc.; Thermo Fisher Scientific Inc.; Becton, Dickinson Biosciences; Agilent Technologies Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Tissue Microarray Market Characteristics

3. Tissue Microarray Market Trends And Strategies

4. Tissue Microarray Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Tissue Microarray Market Size and Growth

  • 5.1. Global Tissue Microarray Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Tissue Microarray Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Tissue Microarray Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Tissue Microarray Market Segmentation

  • 6.1. Global Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Immunohistochemistry
  • Fluorescent In Situ Hybridization
  • Frozen Tissue Array
  • Other Types
  • 6.2. Global Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Deoxyribonucleic Acid (DNA) Microarray
  • Polymerase Chain Reaction (PCR)
  • Next-Generation Sequencing
  • Northern Blotting
  • Western Blotting
  • 6.3. Global Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oncology
  • Gene Expression Profiling
  • Single Nucleotide Polymorphism (SNP) Detection
  • Double-Stranded B-DNA Microarrays
  • Comparative Genomic Hybridization
  • Sequencing Bioinformatics
  • 6.4. Global Tissue Microarray Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pharmaceutical And Biotechnological Companies
  • Research Organization
  • Hospitals

7. Tissue Microarray Market Regional And Country Analysis

  • 7.1. Global Tissue Microarray Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Tissue Microarray Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Tissue Microarray Market

  • 8.1. Asia-Pacific Tissue Microarray Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Tissue Microarray Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Tissue Microarray Market

  • 9.1. China Tissue Microarray Market Overview
  • 9.2. China Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Tissue Microarray Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Tissue Microarray Market

  • 10.1. India Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Tissue Microarray Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Tissue Microarray Market

  • 11.1. Japan Tissue Microarray Market Overview
  • 11.2. Japan Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Tissue Microarray Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Tissue Microarray Market

  • 12.1. Australia Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Tissue Microarray Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Tissue Microarray Market

  • 13.1. Indonesia Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Tissue Microarray Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Tissue Microarray Market

  • 14.1. South Korea Tissue Microarray Market Overview
  • 14.2. South Korea Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Tissue Microarray Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Tissue Microarray Market

  • 15.1. Western Europe Tissue Microarray Market Overview
  • 15.2. Western Europe Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Tissue Microarray Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Tissue Microarray Market

  • 16.1. UK Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Tissue Microarray Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Tissue Microarray Market

  • 17.1. Germany Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Tissue Microarray Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Tissue Microarray Market

  • 18.1. France Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Tissue Microarray Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Tissue Microarray Market

  • 19.1. Italy Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Tissue Microarray Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Tissue Microarray Market

  • 20.1. Spain Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Tissue Microarray Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Tissue Microarray Market

  • 21.1. Eastern Europe Tissue Microarray Market Overview
  • 21.2. Eastern Europe Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Tissue Microarray Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Tissue Microarray Market

  • 22.1. Russia Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Tissue Microarray Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Tissue Microarray Market

  • 23.1. North America Tissue Microarray Market Overview
  • 23.2. North America Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Tissue Microarray Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Tissue Microarray Market

  • 24.1. USA Tissue Microarray Market Overview
  • 24.2. USA Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Tissue Microarray Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Tissue Microarray Market

  • 25.1. Canada Tissue Microarray Market Overview
  • 25.2. Canada Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Tissue Microarray Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Tissue Microarray Market

  • 26.1. South America Tissue Microarray Market Overview
  • 26.2. South America Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Tissue Microarray Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Tissue Microarray Market

  • 27.1. Brazil Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Tissue Microarray Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Tissue Microarray Market

  • 28.1. Middle East Tissue Microarray Market Overview
  • 28.2. Middle East Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Tissue Microarray Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Tissue Microarray Market

  • 29.1. Africa Tissue Microarray Market Overview
  • 29.2. Africa Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Tissue Microarray Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Tissue Microarray Market Competitive Landscape And Company Profiles

  • 30.1. Tissue Microarray Market Competitive Landscape
  • 30.2. Tissue Microarray Market Company Profiles
    • 30.2.1. Roche Group
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Merck & Co. Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Thermo Fisher Scientific Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Becton, Dickinson Biosciences
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Agilent Technologies Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Tissue Microarray Market Other Major And Innovative Companies

  • 31.1. Illumina Inc.
  • 31.2. Bio-Rad Laboratories Inc.
  • 31.3. Qiagen NV
  • 31.4. PerkinElmer Inc.
  • 31.5. Bio-Techne Corporation
  • 31.6. Tristar Group
  • 31.7. Evotec SE
  • 31.8. Precision For Medicine Inc.
  • 31.9. Molecular Devices LLC
  • 31.10. BioIVT LLC
  • 31.11. BioChain Institute Inc.
  • 31.12. Creative Bioarray Co
  • 31.13. 3DHISTECH Ltd.
  • 31.14. Novus Biologicals LLC
  • 31.15. OriGene Technologies Inc.

32. Global Tissue Microarray Market Competitive Benchmarking

33. Global Tissue Microarray Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Tissue Microarray Market

35. Tissue Microarray Market Future Outlook and Potential Analysis

  • 35.1 Tissue Microarray Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Tissue Microarray Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Tissue Microarray Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer